Search

everythinglearnresearchcommunity

for

Search:↓

Deuruxolitinib effectively promotes hair regrowth in adults with alopecia areata.

Geranium pyrenaicum extracts show potential for cancer, antiviral, and enzyme inhibition treatments.

Ritlecitinib shows promise for hair regrowth in alopecia areata patients.

Baricitinib improved severe hair loss in adults over 52 weeks and was safe to use.

Baricitinib, a drug for rheumatoid arthritis, atopic dermatitis, and alopecia areata, is generally safe with low risk of major side effects, even in patients with risk factors. It's also effective in promoting hair regrowth in alopecia areata patients.

Botulinum toxins are safe for various medical and cosmetic uses, but more research is needed for long-term safety and effectiveness in hair growth treatments.

Vimentin and keratin help viruses spread and could be targets for antiviral treatments.

Anifrolumab treatment improves quality of life and reduces disease activity and steroid use in SLE patients.

Patients with rheumatoid arthritis using tofacitinib had more serious side effects than those with alopecia areata.

Some dermatologists in Saudi Arabia prescribe Tofacitinib for hair loss, but many don't due to its unavailability and safety concerns.

The conclusion is that dermatologists need to improve prescription practices to reduce errors and drug interaction risks.

COVID-19 patients with skin signs often stayed in the hospital for less time than those without skin signs.

A fungal infection developed on a herpes scar and was successfully treated with antifungal medication.

The research found that chickenpox virus spreads in skin through blood then to skin cells, while shingles virus moves from nerves to hair follicle areas before infecting skin cells.

Thermography matched the patient's pain levels in a shingles case and might help diagnose shingles without a rash.

A patient's skin rash did not affect the area where a previous viral rash was healing, suggesting a rare immune response.

A woman with a scalp infection and herpes recovered fully after treatment.

AS-OCT is crucial for diagnosing VZV interstitial keratitis and avoiding unnecessary treatments.

Platelet-rich plasma therapy may rarely trigger herpes zoster ophthalmicus.

Herpes zoster can cause lasting nail and hair damage.

The study suggests a link between varicella-zoster virus and segmental vitiligo, with evidence of the virus disrupting skin pigment cells.

A woman's shingles infection triggered her first episode of a rare neurological disorder and blood vessel inflammation.

Herpes zoster can occur with COVID-19 even in healthy individuals.

A patient got Herpes zoster after a knee injection, possibly due to the injection's trauma, but more evidence is needed.

People with obstructive sleep apnea are more likely to get herpes zoster, but nightmares don't affect the risk.

Painful hair loss in an elderly woman was caused by giant cell arteritis, not just aging.

COVID-19 vaccines have been linked to an increase in hair loss conditions.

The dense fine speckled pattern in ANA tests is common in autoimmune diseases, challenging previous beliefs that it was unrelated.

Tofacitinib helped a young woman's severe hair loss and arthritis but not her plaque psoriasis.